Buy Inocain eye drops 0.4%, 5 ml
  • Buy Inocain eye drops 0.4%, 5 ml

Oxybuprocaine

Sentiss Pharma
1815 Items
2019-09-19
Dosage form
Brand & Manufacturer
Package Size
$23.56
Quantity
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Surface anesthesia of the conjunctiva and cornea after the application of eye drops occurs after 30 seconds and lasts for 15 minutes.

Indications

Local anesthesia in ophthalmology:

  • Measurement of intraocular pressure (tonometry).
  • Gonioscopy.
  • Diagnostic scraping conjunctiva.
  • Removing foreign bodies and stitches from the cornea and conjunctiva.
  • Short-term surgery on the cornea and conjunctiva.

Composition

In 1 ml of eye drops 0.4% is contained.

Active substance: aboutXibuprocaine (in the form of hydrochloride) 4 mg.

Excipients: benzalkonium chloride, boric acid, sodium chloride, disodium edetate, water d / i.

No customer reviews for the moment.

Write your review

Write your review

Oxybuprocaine

Dosage and Administration

The drug is instilled into the conjunctival sac 1 drop.

Long-term anesthesia (up to 1 h) provides 3-time instillation with an interval of 4-5 minutes.

Adverse reactions

maybe

Short-term tingling sensation, burning and redness of the conjunctiva, allergic reactions.

Seldom

Keratitis

Contraindications

Individual hypersensitivity to the drug.

Drug interactions

Negative or positive effects are not described in the literature with simultaneous administration of oxybuprocaine and other eye drops traditionally used in the conjunctival sac.

It is noted that oxybuprocaine can theoretically reduce the antibacterial activity of sulfonamides.

Pregnancy and Lactation

Clinical experience in the use of the drug during pregnancy and lactation is not enough. The use of Inokain during pregnancy and during breastfeeding is possible only in cases where the expected benefit of therapy for the mother outweighs the potential risk to the fetus or infant.

Special instructions

The drug is intended only for instillation in the conjunctival sac. Do not use for injection.

Not intended for long-term therapy in the complex treatment of eye diseases.

Prolonged, repeated and prolonged use (as well as other local anesthetics) can lead to persistent corneal opacities.

During anesthesia, it is necessary to protect the eye from irritating chemical effects, foreign bodies and friction.

Use in Pediatrics

There is not enough experience in the use of the drug in children. Application of Inokain in children is possible only in cases when the expected benefit of therapy exceeds the risk of possible side effects.

  • Active ingredient: Oxybuprocaine

Studies and clinical trials of Oxybuprocaine (Click to expand)

Customers who bought this product also bought:

Remowax

Price $56.19
(0)

8 other products in the same category:

arrow_upward